Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Concrete Relief for Vertebral Fractures

Kurt Ullman  |  Issue: April 2008  |  April 1, 2008

“Most vertebral fractures heal within six weeks, so even with conservative treatment, there is usually complete pain relief within that time frame,” says Dr. Dore. “Doctors have jumped on the bandwagon for these procedures because they immediately relieve the pain. But we don’t yet have the data that indicates it is worth the morbidity and mortality to get a couple extra weeks of pain relief.” High levels of virtually overnight pain relief, however, are a major driver at both the doctor and patient level.

“Realistically, we don’t have a lot of treatments for the pain associated with acute vertebral fractures, and most of the options are bad,” says Dr. Mody. “Physicians are hard pressed to justify not doing the procedure when someone is in pain, the procedure is minimally invasive, and there are few bad outcomes.”

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

“BK does have some theoretical benefits, such as improving vertebral body height, which could improve posture,” says Dr. Smuck. “However, it still does nothing to correct sagital balance and forward stooping that results from multiple vertebral fractures. Even if it does increase vertebral body height, it doesn’t look like this translates to overall posture improvement.”

Price the Main Difference Between Procedures

The area where all three experts agree is there is a major difference is in the price of the two procedures. Most of the difference is that BK is coded as an open reduction and internal fixation procedure. This code requires that a patient be admitted to a hospital overnight before reimbursement will be approved. Therefore, BK costs about 2.5 times more than vertebroplasty.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

In addition, BK requires a proprietary system that can cost up to $1,000 per patient. VP uses mainly PMMA and standard injection systems that are available off the shelf.

Another area of agreement is that prevention is much better than either procedure. “While this is a wonderful procedure that holds out hope of being very helpful, the most important treatment is to not let the fracture happen in the first place,” says Dr. Mody. “Early screening, medication, supplementation, and education will always be the mainstay of osteoporosis treatment.”

Kurt Ullman is a freelance writer based in Indiana.

References

  1. Cummings SR, Melton LJ. Epidemiology and outcomes of osteoporotic fractures. Lancet. 2002; 359:1761-1767.
  2. Jensen ME, McGraw JK, Cardella JF, et al. Position statement on percutaneous vertebral augmentation. J Vasc Interv Radiol. 2007;18:325-330.

Page: 1 2 3 | Single Page
Share: 

Filed under:ConditionsOsteoarthritis and Bone Disorders Tagged with:Joint SurgeryOsteoporosisPainTreatmentvertebral fracture

Related Articles

    Case Report: Rheumatoid Arthritis Complicated by Large Granular Lymphocytic Leukemia

    November 14, 2021

    Large granular lymphocytic (LGL) leukemia is a rare, chronic, lymphoproliferative disorder of cytotoxic T cell or natural killer cell lineage with an annual incidence of 0.72 cases per 1 million people in the U.S.1 The most common sub­type of LGL leukemia, T-LGL leukemia, follows an indolent disease course and accounts for approximately 85% of cases….

    Unexpected Benefits of Bisphosphonates after Hip Fracture

    February 3, 2012

    Recent trials show this bisphosphonates can reduce subsequent hip fractures and mortality, while remaining cost effective.

    Targeted Vertebral Fracture Assessment

    September 7, 2020

    A Canadian study sought to identify individuals at high fracture risk and provide them with pharmacotherapy to prevent fractures. They found the assessment of hip and lumbar dual-energy X-ray absorptiometry scans for vertebral fracture can be useful in the identification of women and men aged 70 years and older who should qualify for anti-osteoporosis treatment…

    Osteoporosis Experts Discuss Bisphosphonate Holidays

    November 24, 2020

    ACR CONVERGENCE 2020—Bisphosphonates are an important treatment for millions of older Americans with osteoporosis because the drugs inhibit osteoclastic bone resorption to reduce the risk of painful, debilitating fractures.1 More than 20 years ago, data emerged that bisphosphonates have a long terminal half-life.2 So after years of therapy, could some patients take a drug holiday?…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences